Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05241028
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2022-01-24
Brief Title:
Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
Sponsor:
Organization:
Hebei Medical University Fourth Hospital